P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 255 500 KRW 0.79%
Market Cap: 2.7T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
PharmaResearch Co Ltd

Wall Street analysts forecast PharmaResearch Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 287 785.71 KRW with a low forecast of 262 600 KRW and a high forecast of 315 000 KRW.

Lowest
Price Target
262 600 KRW
3% Upside
Average
Price Target
287 785.71 KRW
13% Upside
Highest
Price Target
315 000 KRW
23% Upside
PharmaResearch Co Ltd Competitors:
Price Targets
NBIX
Neurocrine Biosciences Inc
23% Upside
DNLI
Denali Therapeutics Inc
103% Upside
SWTX
SpringWorks Therapeutics Inc
92% Upside
NRIX
Nurix Therapeutics Inc
65% Upside
PRME
Prime Medicine Inc
340% Upside
SVE
Synthaverse SA
56% Upside
IDYA
IDEAYA Biosciences Inc
118% Upside
KRON
Kronos Bio Inc
73% Upside

Revenue
Forecast

Revenue Estimate
PharmaResearch Co Ltd

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's revenue is 27%. The projected CAGR for the next 3 years is 23%.

27%
Past Growth
23%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
PharmaResearch Co Ltd

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 24%. The projected CAGR for the next 3 years is 30%.

24%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
PharmaResearch Co Ltd

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 25%.

25%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PharmaResearch Co Ltd's stock price target?
Price Target
287 785.71 KRW

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 287 785.71 KRW with a low forecast of 262 600 KRW and a high forecast of 315 000 KRW.

What is PharmaResearch Co Ltd's Revenue forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's revenue is 27%. The projected CAGR for the next 3 years is 23%.

What is PharmaResearch Co Ltd's Operating Income forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 24%. The projected CAGR for the next 3 years is 30%.

What is PharmaResearch Co Ltd's Net Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 25%.

Back to Top